Skip to main content

Table 1 Antiviral and toxicity activities of compounds on WNV-infected eNPCs

From: An equine iPSC-based phenotypic screening platform identifies pro- and anti-viral molecules against West Nile virus

Compounds

Type

Viral replication

Cytotoxicity (10 µM)

2′-C-methylcytidine

DAA-NA

AV

 

25-Hydroxycholesterol

HDA

 

Tx

Abacavir

DAA-RTI

NoA

 

Adefovir dipivoxil

DAA-HVI

 

Tx

Amantadine

HDA

NoA

 

Arbidol

HDA

AV

 

Atorvastatin

HDA

PV

 

Brequinar

HDA

 

Tx

Capecitabine

N/A

NoA

 

Cidofovir

DAA-HVI

 

Tx

Cladribine

N/A

 

Tx

Clofarabine

N/A

 

Tx

Cytarabine

N/A

 

Tx

Decitabine

DAA-NA

 

Tx

Didanosine

DAA-RTI

NoA

 

DMXAA

HDA

NoA

 

Eflornithin (dfmo)

HDA

NoA

 

Emtricitabine

DAA-RTI

NoA

 

F83233

HDA

 

Tx

F83233RS

HDA

 

Tx

Famciclovir

DAA-HVI

NoA

 

Favipiravir

DAA-NA

NoA

 

Fludarabine

DAA-NA

 

Tx

Fluorouracile

DAA-NA

 

Tx

Gemcitabine

DAA-NA

 

Tx

Isatin

HDA

NoA

 

Lamivudine

DAA-RTI

NoA

 

Maribavir

DAA

NoA

 

Mercaptopurine

DAA-NA

 

Tx

Mycophenolic acid

HDA

 

Tx

Nelarabine

N/A

NoA

 

Penciclovir

DAA-HVI

NoA

 

Proguanil

HDA

NoA

 

Ribavirin

DAA-NA, HDA

AV

 

Sofosbuvir

DAA-NA

NoA

 

Stavudine

DAA-RTI

NoA

 

Telbivudine

DAA-RTI

NoA

 

Tenofovir disoproxil

DAA-RTI

NoA

 

Thioguanine

DAA-NA

 

Tx

Valaciclovir

DAA-HVI

NoA

 

Valganciclovir

DAA-HVI

NoA

 
  1. DAA: direct-antiviral activity, HDA: host-directed antiviral, NA: nucleoside analog, RTI: reverse transcriptase inhibitor, HVI: herpes virus inhibitor, Tx: toxic, AV: antiviral activity, NoA: no activity, PV: pro-viral activity.